Michael Scolaro

Michael Scolaro

Sep 18, 2017

Group 6 Copy 70
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Saving lives with synthetic antivenoms: looking for novel solutions to Lonomia envenoming in Colombia

    Venomous caterpillars of the genus Lonomia cause deadly accidents in Colombia. In Brazil it is estimated...

    How do chemical exposures trigger autoimmune diseases?

    The cause of onset of autoimmune disease is poorly understood, but may be linked to exposure to certain...

    Mosquitoes as Flying Syringes: The Solution to Rapid Zika Monitoring

    Yes, mosquitoes are flying syringes! They sample human blood as a normal part of their life cycle. We can...

    Backer Badge Funded